Umifenovir clinical trials
Also written Arbidol.
How each study uses umifenovir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the umifenovir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 5
Shengjing Hospital (1) · Capital Medical University (1) · Jieming QU (1) · Zheng Liu (1) · Shahid Beheshti University of Medical Sciences (1) · Pharmstandard (1)
Studies
Open first, then newest update. How each study uses umifenovir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Efficacy and Safety of Arbidol in the Treatment of Allergic RhinitisRecruitingNot applicableZheng LiuNCT06462417Written as Arbidol
- The Efficacy and Safety of Arbidol in Reducing the Frequency of AECOPD.CompletedPhase 4Shengjing HospitalNCT03851991Written as Arbidol
- Severe Influenza Trial of ARbidolCompletedPhase 3Capital Medical UniversityNCT03787459Written as Arbidol
- Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel CoronavirusCompletedPhase 4Jieming QUNCT04260594Written as Arbidol
- Umifenovir in Hospitalized COVID-19 PatientsStatus unknownPhase 4Shahid Beheshti University of Medical SciencesNCT04350684Written as Umifenovir
- A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common ColdStatus unknownPhase 4PharmstandardNCT01651663Written as Arbidol (Umifenovir)
As the comparator · 2 — what is tested is compared with umifenovir
- The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting ConditionsStatus unknownPhase 1Atabay Kimya Sanayi Ticaret A.S.NCT04476719Written as ARBIDOL 100 MG KAPSUL
- The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus InfectionCompletedPhase 4Guangzhou 8th People's HospitalNCT04252885Written as Arbidol
Codes
What other systems call umifenovir · ClinicalTrials.gg INT003785
- MeSH (NLM) C086979umifenovirConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 93M09WW4RUUMIFENOVIRConfirmed FDA, NLM, Wikidata
- Wikidata Q27271599umifenovirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152799UmifenovirOne source FDA
- DrugBank DB13609One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C086979 | umifenovir | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 93M09WW4RU | UMIFENOVIR | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27271599 | umifenovir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152799 | Umifenovir | One source FDA |
| DrugBank | DB13609 | — | One source Wikidata |
Also registered as umifenovir hydrochloride (UNII 8CXV4OU367), umifenovir hydrochloride monohydrate (UNII YFE0A1FOSX) and umifenovir sulfoxide (UNII K7Z9APJ3SC).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.